Information Provided By:
Fly News Breaks for July 24, 2015
HZNP, DEPO
Jul 24, 2015 | 11:09 EDT
WallachBeth raised its price target on Depomed (DEPO) to $33 from $26 to reflect the most recent takeover offer made by Horizon Pharma (HZNP), but maintains its Hold rating on the stock, as the firm remains skeptical that Depomed will be content with Horizon’s offer. The firm adds that it does not anticipate other suitors to emerge for Depomed.
News For DEPO;HZNP From the Last 2 Days
There are no results for your query DEPO;HZNP